Microbiota effects on cancer: from risks to therapies
Metrics: PDF 3242 views | HTML 5475 views | ?
Domenica Rea1,*, Giovanni Coppola1,*, Giuseppe Palma1, Antonio Barbieri1, Antonio Luciano1, Paola Del Prete2, Sabrina Rossetti3, Massimiliano Berretta4, Gaetano Facchini3, Sisto Perdonà5, Maria Caterina Turco6 and Claudio Arra1
1S.S.D Sperimentazione Animale, Istituto Nazionale Tumori, IRCCS, “Fondazione G. Pascale”, Naples, Italy
2Direzione Scientifica, Istituto Nazionale Tumori, IRCCS, “Fondazione G. Pascale”, Naples, Italy
3Division of Medical Oncology, Department of Uro-Gynaecological Oncology, Istituto Nazionale Tumori, IRCCS, “Fondazione G. Pascale”, Naples, Italy
4Department of Medical Oncology, CRO- Aviano, National Cancer Institute, Aviano, Italy
5Department of Urology, Istituto Nazionale Tumori, IRCCS, “Fondazione G. Pascale”, Naples, Italy
6Department of Medicine and Surgery, University of Salerno, Baronissi, Salerno, Italy
*These authors have contributed equally to this work
Giuseppe Palma, email: [email protected]
Antonio Barbieri, email: [email protected]
Keywords: gut microbiota; cancer; inflammation; probiotics; colon rectal cancer
Received: August 03, 2017 Accepted: February 27, 2018 Published: April 03, 2018
Gut microbiota, a group of 1014 bacteria, eukaryotes and virus living in gastrointestinal tract, is crucial for many physiological processes in particular plays an important role in inflammatory and immune reactions. Several internal and external factors can influence this population, and shifts in their composition, have been demonstrated to contribute and affect different diseases. During dysbiosis several bacteria related to inflammation, one of the most necessary factors in carcinogenesis; it has been shown that some bacterial strains through deregulation of different signals/pathways may affect tumor development through the production of many factors. Gut microbiota might be considered as a holistic hub point for cancer development: direct and indirect involvements have been studying in several neoplasms such as colon rectal cancer, hepatocellular carcinoma and breast cancer. This review discuss over the evidence of crosstalk between gut microbiota and cancer, its ability to modulate chemotherapy, radiotherapy and immunotherapy, and the possibility that the intestinal microbial is a new target for therapeutic approaches to improve the prognosis and quality of life of cancer patients.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.